Atlas Trials

Prostate Cancer Biomarker Enrichment and Treatment Selection

Clinical trial NCT03385655 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03385655
Sponsor
Canadian Cancer Trials Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2018-08-01
Primary completion
2024-10-07
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.